Showing 19 of 19 recruiting trials for “Extranodal nasal NK/T cell lymphoma”
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT07450040 ↗
Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
RecruitingNCT06362148 ↗
Circulating Tumor DNA in Peripheral T-cell Lymphomas
👨⚕️ Francesco A d'Amore, MD, DMSc, Aarhus University Hospital and Aarhus University📍 1 site📅 Started Mar 2024View details ↗
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
👨⚕️ Stefano Luminari, MD, Ematologia, AUSL IRCCS Reggio Emilia📍 2 sites📅 Started Feb 2022View details ↗
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
👨⚕️ Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Nov 2016View details ↗
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →